Get started
Author

Jim S. Yan

Observed name: Jim Yan
OpenAlex ID: A5111960889
Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1
2006 · Gizem Rizki, Lorenzo Arnaboldi, et al. · Journal of Lipid Research · 265
PDF
Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis
1999 · Xiao Xu, Daseng Yang, et al. · Proceedings of the National Academy of Sciences · 91
Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis
2009 · Michael K. Pickens, Jim S. Yan, et al. · Journal of Lipid Research · 90
Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury
2007 · Gene S. Lee, Jim S. Yan, et al. · Journal of Lipid Research · 68
Stress Signaling in the Methionine-Choline–Deficient Model of Murine Fatty Liver Disease
2010 · Russell K. Soon, Jim S. Yan, et al. · Gastroenterology · 57
PDF
Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis
2012 · Meena Upadhyaya, Gill Spurlock, et al. · Human Mutation · 51
Chromosome abnormalities diagnosed in utero: a Japanese study of 28 983 amniotic fluid specimens collected before 22 weeks gestations
2015 · Miyuki Nishiyama, Jim Yan, et al. · Journal of Human Genetics · 25
Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine/endotoxin toxicity
2005 · Jennifer C. Hanson, Michele K. Bostick, et al. · Journal of Hepatology · 20
Male-to-Female Sex Ratios of Abnormalities Detected by Fluorescence In Situ Hybridization in a Population of Chronic Lymphocytic Leukemia Patients
2013 · Eduardo S. Cantú, John R. McGill, et al. · Hematology Reports · 14
PDF
Development of a LAG-3 immunohistochemistry assay for melanoma
2022 · Lori Johnson, Bryan McCune, et al. · Journal of Clinical Pathology · 13
PDF
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn’s Disease
2024 · Sarah Harris, Brian G. Feagan, et al. · Digestive Diseases and Sciences · 12
PDF
Safety, Pharmacokinetic, Immunogenicity, and Pharmacodynamic Responses in Healthy Volunteers Following a Single Intravenous Injection of Purified Staphylococcal Protein A
2013 · Charles Ballow, Anissa Leh, et al. · The Journal of Clinical Pharmacology · 12
S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn’s Disease (CD): Results From the Phase 2 STEPSTONE Study
2023 · Sarah Harris, Brian G. Feagan, et al. · The American Journal of Gastroenterology
Abstract 151: Development of a robust MGMT promoter methylation assay for glioblastoma multiforme
2020 · Benjamin Avery, Neal Englert, et al. · Cancer Research
Development of algorithms for a quantitative real time-PCR assay to determine EGFRvIII status in glioblastoma patients from rindopepimut clinical trials.
2015 · Jim Yan, Donald James Witt, et al. · Journal of Clinical Oncology
Abstract 5602: Identification of ethnic specific differences in breast cancer and normal breast tissue
2011 · Lisa L. Baumbach, Carmen Gomez, et al. · Cancer Research
Abstract B35: Defining multiethnic genome-wide transcriptional signatures in normal and cancerous breast tissue using paraffin-embedded samples
2009 · Lisa Baumbach‐Reardon, Mary Ellen Ahearn, et al. · Cancer Epidemiology and Prevention Biomarkers
Opposing effects of the Aβ peptide and its precursor protein on the proapoptotic P53 pathway
2000 · Li Gan, Jim Yan, et al. · Neurobiology of Aging
Works count: 18
Citation count: 712
H-index: 11
I10-index: 12
Year
Topic
Type